Mechanistically, miRNA-206-3p targets TLR4 to regulate the classical TLR4/MyD88/NF-κB/NLRP3 inflammatory pathway and may have major scientific value as a new therapeutic target for ALI. Here, NLRP3 is linked to acute respiratory distress syndrome.